David Charmoy Buxton is a Orlando, Florida based psychiatrist with 15 years of experience in Hospice and Palliative Medicine. He completed his graduation in 2009. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of David Charmoy Buxton is ME143143 for Hospice and Palliative Medicine in Florida. His current practice location is 2501 N Orange Ave Ste 235, Orlando. Patients can reach him at 407-303-7270 or can fax him at 407-303-2553. David Charmoy Buxton is MD in Hospice and Palliative Medicine and his NPI number (Unique professional ID assigned by NPPES) is 1831329655. David Charmoy Buxton prevent and relieve the suffering experienced by patients with life-limiting illnesses. He works with an interdisciplinary hospice or palliative care team to maximize quality of life while addressing physical, psychological, social and spiritual needs of both patient and family throughout the course of the disease, through the dying process, and beyond for the family. He has expertise in the assessment of patients with advanced disease; the relief of distressing symptoms; the coordination of interdisciplinary patient and family-centered care in diverse venues; the use of specialized care systems including hospice; the management of the imminently dying patient; and legal and ethical decision making in end-of-life care.
Complete Profile:
David Charmoy Buxton speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
David Charmoy Buxton
Specialization:
Hospice and Palliative Medicine
Gender:
Male
Credentials:
MD
Experience:
15+ years
Medical School Attended:
Other
Graduation Year:
2009
Accepts Medicare Assignment:
Yes
Practice Address:
2501 N Orange Ave Ste 235, Orlando, Florida, 32804-4659
Phone:
407-303-7270
Fax:
407-303-2553
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
5092950527
Enrollment ID:
I20200325001945
NPI Number:
1831329655
NPI Enumeration Date:
15 Jul, 2009
NPI Last Update On:
18 Mar, 2020
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for David Charmoy Buxton are as mentioned below.
License Number
Specialization
State
Status
ME143143
Hospice and Palliative Medicine
Florida
Primary
0101257173
Hospice and Palliative Medicine
Virginia
Secondary
ME143143
Child & Adolescent
Florida
Secondary
0101257173
Psychiatry
Virginia
Secondary
ME143143
Psychiatry
Florida
Secondary
0101257173
Child & Adolescent
Virginia
Secondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
(100007)
Orlando, FL
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which David Charmoy Buxton is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Florida Hospital Medical Group Inc (0749186153)
1016
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
David Charmoy Buxton 2501 N Orange Ave Ste 235, Orlando, Florida
Zip:
32804-4659
Phone Number:
407-303-7270
Fax Number:
407-303-2553
Patients can reach David Charmoy Buxton at 2501 N Orange Ave Ste 235, Orlando, Florida or can call to book an appointment on 407-303-7270.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.